ESC Premium Access

Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study.

Congress Presentation

About the speaker

Associate Professor Daniele Pastori

Sapienza University of Rome, Rome (Italy)
1 presentation
0 follower

6 more presentations in this session

Effects of EDOXaban on the cellular and protein phase of coagulation in coronary artery disease patients on dual antiplatelet therapy with aspirin and clopidogrel: a randomized pharmacodynamic study

Speaker: Professor D. Angiolillo (Jacksonville, US)


Comparative effectiveness and safety of non-vitamin K oral anticoagulants and warfarin in non-valvular atrial fibrillation - a cohort study in 3 Nordic countries

Speaker: Professor S. Johnsen (Aalborg, DK)


Anti-inflammatory effects of direct oral anticoagulants in patients with non-valvular atrial fibrillation: insights from 2216 patients in the DIRECT registry

Speaker: Doctor Y. Sotomi (Osaka, JP)


Safety and efficacy of non-vitamin k antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 27 studies and 446,944 patients

Speaker: Doctor A. Silverio (Salerno, IT)


Relationship between international normalized ratio variability, quality of anticoagulation control and outcomes in patients with atrial fibrillation: an AFFIRM post-hoc analysis

Speaker: Doctor M. Proietti (Milan, IT)


Access the full session

Poster Session 4 - Anticoagulant therapy

Speakers: Associate Professor D. Pastori, Professor D. Angiolillo, Professor S. Johnsen, Doctor Y. Sotomi, Doctor A. Silverio...

About the event



31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk